Reversal of symptomatic tumoral narcolepsy, with normalization of CSF hypocretin level

Neurology. 2007 Sep 18;69(12):1300-1. doi: 10.1212/01.wnl.0000276948.46213.64.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Brain / pathology
  • Brain / physiopathology*
  • Brain Neoplasms / complications*
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / pathology
  • Electroencephalography
  • HLA-DQ Antigens / genetics
  • HLA-DQ beta-Chains
  • Humans
  • Hypothalamus / pathology
  • Hypothalamus / physiopathology
  • Intracellular Signaling Peptides and Proteins / cerebrospinal fluid
  • Intracellular Signaling Peptides and Proteins / deficiency*
  • Lymphoma, B-Cell / complications*
  • Lymphoma, B-Cell / drug therapy
  • Lymphoma, B-Cell / pathology
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Narcolepsy / cerebrospinal fluid
  • Narcolepsy / etiology*
  • Narcolepsy / physiopathology
  • Neuropeptides / cerebrospinal fluid
  • Neuropeptides / deficiency*
  • Orexins
  • Treatment Outcome

Substances

  • HLA-DQ Antigens
  • HLA-DQ beta-Chains
  • HLA-DQB1 antigen
  • Intracellular Signaling Peptides and Proteins
  • Neuropeptides
  • Orexins